scispace - formally typeset
Journal ArticleDOI

Therapeutic potential of resveratrol: the in vivo evidence.

Joseph A. Baur, +1 more
- 01 Jun 2006 - 
- Vol. 5, Iss: 6, pp 493-506
Reads0
Chats0
TLDR
A comprehensive and critical review of the in vivo data on resveratrol is provided, and its potential as a therapeutic for humans is considered.
Abstract
Resveratrol, a constituent of red wine, has long been suspected to have cardioprotective effects. Interest in this compound has been renewed in recent years, first from its identification as a chemopreventive agent for skin cancer, and subsequently from reports that it activates sirtuin deacetylases and extends the lifespans of lower organisms. Despite scepticism concerning its bioavailability, a growing body of in vivo evidence indicates that resveratrol has protective effects in rodent models of stress and disease. Here, we provide a comprehensive and critical review of the in vivo data on resveratrol, and consider its potential as a therapeutic for humans.

read more

Citations
More filters
Journal ArticleDOI

Mitochondria-centric Review of Polyphenol Bioactivity in Cancer Models

TL;DR: It is argued that the physicochemical properties of polyphenols are responsible for their anticancer properties by virtue of their protonophoric and pro-oxidant properties rather than their specific effects on downstream molecular targets.
Journal ArticleDOI

Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress.

TL;DR: The presence of trans-resveratrol at micromolar concentrations in the incubation medium protected the erythrocytes from t-BHP-induced oxidative stress, as evidenced by the decrease in the MDA level and the protein carbonyl group content.
Journal ArticleDOI

Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: protection by chronic oral intake of resveratrol.

TL;DR: It is suggested that chronic RSV treatment may induce nephrotoxicity, as demonstrated that a 12-month RSV intake resulted in significant elevation of 8-iso-PGF(2 alpha) and PCC in kidney.
Journal ArticleDOI

Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli.

TL;DR: The study described here paves the way to the development of a simple and economical process for microbial production of resveratrol by utilizing a recombinant malonate assimilation pathway from Rhizobium trifolii and optimizing the expression level of the rate-limiting enzyme TAL based on reducing mRNA structure of 5′ region.
Journal ArticleDOI

Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells.

TL;DR: It is suggested that resveratrol may be useful for prevention of UVB‐mediated damages including skin cancer and enhancing the response of radiation therapies against hyperproliferative, precancerous and neoplastic conditions.
References
More filters
Journal ArticleDOI

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

TL;DR: Experiments with guinea-pig lung suggest that some of the therapeutic effects of sodium salicylate and aspirin-like drugs are due to inhibition of the synthesis of prostaglandins.
Journal ArticleDOI

Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

TL;DR: It is suggested that resveratrol, a common constituent of the human diet, merits investigation as a potential cancer chemopreventive agent in humans.
Journal ArticleDOI

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

TL;DR: The potent activator resveratrol, a polyphenol found in red wine, lowers the Michaelis constant of SIRT1 for both the acetylated substrate and NAD+, and increases cell survival by stimulating Sirt1-dependent deacetylation of p53.
Journal ArticleDOI

Wine, alcohol, platelets, and the French paradox for coronary heart disease

TL;DR: Data from Caerphilly, Wales, show that platelet aggregation, which is related to CHD, is inhibited significantly by alcohol at levels of intake associated with reduced risk of CHD.
Journal ArticleDOI

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

TL;DR: A balance between formation of anti- and pro-aggregatory substances by enzymes could also contribute to the maintenance of the integrity of vascular endothelium and explain the mechanism of formation of intra-arterial thrombi in certain physiopathological conditions.
Related Papers (5)